Guidance
Evidence-based recommendations on EarlyCDT Lung for assessing the risk of lung cancer in solid lung nodules.
Is this guidance up to date?
Next review: 2025
Guidance development process
How we develop NICE diagnostics guidance
This guidance replaces the NICE medtech innovation briefing on EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules (MIB209).